Stephen Evans Selected Research

Stephen Evans Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 07/2005
3	Breast Neoplasms (Breast Cancer) 06/2021 - 04/2016
2	COVID-19 11/2023 - 01/2022
2	Myocardial Infarction 11/2016 - 06/2006
2	Vascular Diseases (Vascular Disease) 11/2016 - 01/2009
2	Colorectal Neoplasms (Colorectal Cancer) 12/2013 - 01/2011
2	Carcinogenesis 08/2006 - 07/2005
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2005 - 07/2005
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Dementia (Dementias) 01/2021
1	Human Influenza (Influenza) 01/2020
1	Meningioma (Meningiomas) 08/2019
1	Mood Disorders (Mood Disorder) 01/2018
1	Autism Spectrum Disorder 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Muscular Diseases (Myopathy) 11/2016
1	Rhabdomyolysis 11/2016
1	Stroke (Strokes) 11/2016
1	Myalgia 11/2016
1	Diabetes Mellitus 11/2016
1	Respiratory Sounds (Crackle) 06/2016
1	Thrombotic Microangiopathies 03/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Hypertension (High Blood Pressure) 04/2012
1	Prostatic Neoplasms (Prostate Cancer) 04/2012
1	Heart Failure 04/2012
1	Pneumonia (Pneumonitis) 04/2011
1	Rheumatoid Arthritis 04/2011
1	Inflammation (Inflammations) 04/2011
1	Urinary Tract Infections (Urinary Tract Infection) 10/2010
1	Venous Thromboembolism 01/2009
1	Infections 01/2009
1	Autoimmune Diseases (Autoimmune Disease) 01/2009
1	Lung Neoplasms (Lung Cancer) 08/2006
1	Carcinoma (Carcinomatosis) 07/2005
1	Stomach Neoplasms (Stomach Cancer) 07/2005
1	Thrombosis (Thrombus) 09/2002

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016 - 01/2009
3	Transforming Growth Factor beta (TGF-beta)IBA 08/2006 - 07/2005
2	Polymethyl Methacrylate (Sol)IBA 06/2021 - 01/2021
2	LDL CholesterolIBA 01/2021 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 08/2006 - 07/2005
1	molnupiravirIBA 11/2023
1	sotrovimabIBA 11/2023
1	COVID-19 VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	Oxygen (Dioxygen)IBA 06/2021
1	Biocompatible Materials (Biomaterials)IBA 06/2021
1	LipidsIBA 01/2021
1	methylallyl trisulfide (MATS)IBA 01/2021
1	CholesterolIBA 01/2021
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Rimantadine FDA LinkGeneric 01/2020
1	Protons (Proton)IBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2019
1	capivasertibIBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Capsules (Microcapsules)IBA 01/2018
1	TabletsIBA 01/2018
1	Atorvastatin (Lipitor)FDA Link 11/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2016
1	Vitamin D FDA LinkGeneric 06/2016
1	Interferon-betaIBA 03/2014
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2014
1	Insulin (Novolin)FDA Link 04/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2012
1	Angiotensin Receptor AntagonistsIBA 04/2012
1	Metformin (Glucophage)FDA LinkGeneric 04/2012
1	Antihypertensive Agents (Antihypertensives)IBA 04/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2012
1	SteroidsIBA 04/2011
1	SDMIBA 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2010
1	insulin receptor-related receptor (IRR)IBA 10/2010
1	Penicillins (Penicillin)FDA Link 10/2010
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2010
1	UbiquitinIBA 07/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2005
1	SpectrinIBA 07/2005
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2002

Therapy/Procedure

3	Therapeutics 11/2023 - 11/2016
2	Microbubbles 01/2017 - 12/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023
1	Secondary Prevention 11/2016
1	Mammaplasty (Breast Reconstruction) 04/2016
1	Duration of Therapy 04/2012
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2006